[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355916-105":59,"doc-detail-355916-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","kaiso-modulates-androgen-receptor-expression-in-triple-negative-breast-cancer","Kaiso modulates androgen receptor expression in triple-negative breast cancer","","Triple-negative breast cancer (TNBC) is an aggressive subtype with limited biomarker-defined options, and most tumors show low androgen receptor (AR) expression despite occasional responses to AR inhibitors. Women of African ancestry face disproportionate TNBC burden and higher mortality, suggesting genetic susceptibility. This study tests whether the transcription factor Kaiso regulates AR and shapes AR-negative/quadruple-negative biology by combining public dataset and tissue microarray profiling with CRISPR-Cas9 Kaiso knockout models to assess AR control, metastasis-related targets, and enzalutamide sensitivity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/kaiso-modulates-androgen-receptor-expression-in-triple-negative-breast-cancer/355916/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/kaiso-modulates-androgen-receptor-expression-in-triple-negative-breast-cancer/355916.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are targeted treatment options limited for most TNBC patients?","Question",{"text":112,"@type":113},"TNBC tumors generally lack the biomarkers needed for conventional targeted therapies, and most show low androgen receptor (AR) expression, which reduces response to AR-targeted approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study investigate Kaiso’s role in AR regulation?",{"text":117,"@type":113},"The researchers profiled TNBC datasets and tissue microarrays, generated CRISPR-Cas9 Kaiso knockout TNBC cell lines, and measured AR expression and promoter regulation using chromatin immunoprecipitation, immunoblotting, RT-qPCR, and promoter-reporter assays.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did Kaiso knockout have on enzalutamide response and tumor behaviors?",{"text":121,"@type":113},"Kaiso knockout increased AR expression, reduced migration and invasion, lowered the AR target ACSL4, and made cells more sensitive to the AR inhibitor enzalutamide compared with parental cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355916,1790615040,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":138,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398046744996,"Ali Fairbairn et al. Breast Cancer Research (2026) 28:116 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-026-02299-4](https://doi.org/10.1186/s13058-026-02299-4)  \nRESEARCH Open Access  \nKaiso modulates androgen receptor expression in triple-negative breast cancer  \nStephanie Ali Fairbairn1,2*, Kyle Kim1,2, Robert W. Cowan 1,2, Lindyann R. Lessey 1,2, Melody Fanaian1,2, Hanad Adan1,2, Sailaja Golamari3, Ryan Rattan3 and Juliet M. Daniel 1,2*  \nAbstract  \nBackground Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that presents therapeutic challenges due to the lack of expression of biomarkers required for conventional targeted treatments. Although a subset ofTNBC tumors respond to androgen receptor (AR) inhibitors, the majority exhibit low AR expression and poor outcomes. These AR-negative tumors have been subclassified as quadruple-negative breast cancer (QNBC) . Notably, women of African ancestry (WAA) experience a disproportionate burden ofTNBC and higher mortality compared to white women, a disparity not fully explained by socio-economic factors, thus suggesting a genetic susceptibility. The transcription factor Kaiso, previously implicated inTNBC progression and poor survival in WAA patients, may play a key role in QNBC biology.  \nMethods Expression profiling ofTNBC tumors from WAA and white women was performed using publicly available datasets and tissue microarrays. To examine the role of Kaiso in AR regulation, we generated CRISPR-Cas9 Kaiso knockout TNBC cell lines and assessed AR expression using chromatin immunoprecipitation, immunoblotting,  \nRT-qPCR and promoter-reporter assays. Cell viability, migration and invasion assays were used to evaluate the effect of Kaiso knockout on sensitivity to the AR inhibitor enzalutamide.  \nResults High Kaiso expression combined with low AR expression correlated with poorer survival across breast cancer subtypes, including TNBC. WAA expressed significantly lower AR expression and a higher prevalence of the QNBC subtype. Kaiso associated with the endogenous AR promoter, and Kaiso knockout inTNBC cells increased AR expression while reducing ACSL4, an AR target gene that promotes metastasis through phospholipid remodeling. Notably, Kaiso knockout cells were more sensitive to enzalutamide compared to parental cells and reduced migration and invasion.  \nConclusion Collectively, our findings implicate Kaiso as a key player inTNBC and QNBC, highlighting its potential as adruggable target for improving outcomes in these aggressive breast cancer subtypes.  \nKeywords Triple-negative breast cancer (TNBC), Quadruple-negative breast cancer (QNBC), Women of African ancestry, Kaiso, Androgen receptor, Disparities  \n*Correspondence: Stephanie Ali Fairbairn [alifairs@mcmaster.ca](alifairs@mcmaster.ca)[ ](alifairs@mcmaster.ca)Juliet M. Daniel [danielj@mcmaster.ca](danielj@mcmaster.ca)  \n1Department of Biology, McMaster University, Hamilton, ON, Canada 2Centre for Discovery in Cancer Research (CDCR), McMaster University, Hamilton, ON, Canada  \n3Department of Pathology, San-Fernando Teaching Hospital, SanFernando , Trinidad and Tobago  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory","cbCaip7XO2v5KXOL","https://ap.wps.com/l/cbCaip7XO2v5KXOL","pdf",4785597,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Why are targeted treatment options limited for most TNBC patients?\",\"answer\":\"TNBC tumors generally lack the biomarkers needed for conventional targeted therapies, and most show low androgen receptor (AR) expression, which reduces response to AR-targeted approaches.\"},{\"question\":\"How did the study investigate Kaiso’s role in AR regulation?\",\"answer\":\"The researchers profiled TNBC datasets and tissue microarrays, generated CRISPR-Cas9 Kaiso knockout TNBC cell lines, and measured AR expression and promoter regulation using chromatin immunoprecipitation, immunoblotting, RT-qPCR, and promoter-reporter assays.\"},{\"question\":\"What effects did Kaiso knockout have on enzalutamide response and tumor behaviors?\",\"answer\":\"Kaiso knockout increased AR expression, reduced migration and invasion, lowered the AR target ACSL4, and made cells more sensitive to the AR inhibitor enzalutamide compared with parental cells.\"}]","Kaiso modulates androgen receptor expression in triple-negative breast cancer | PDF",1790121721,43,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67cd6c79bf941dbdcf234cd463f69c92.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5fdc693115715b91fe2c15a4e94fca5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d42baa7e2fc1666e2074ab721651b34f.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32ffda30b85e8eb240665a9781480f3d.webp",980,1306]